Skip to main content
. 2020 Jul 2;54(6):1489–1500. doi: 10.1007/s43441-020-00176-6
PE team member companies Abbvie, Allergan, Amgen, Astellas, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, EMD Serono/Merck Healthcare KGaA, GlaxoSmithKline, Janssen, Lilly, Merck, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, and UCB Pharma
SME roles

Decision maker for study design (e.g., clinical science/ development leaders)

Influencer responsible for study design and conduct (e.g., operational study team, biostatistics, and patient-reported outcomes [PRO] scientists)

Strategic driver of patient centricity (e.g., corporate strategy executives, Chief Patient Officers, patient network and advisory leaders)

Decision maker for operational plans (e.g., clinical operations leaders)

Senior Stakeholder Engagement Manager

Vice President Medical Science, Oncology

Clinical Operations Lead; Global Program Lead; Innovation Head

Individuals who conduct external patient engagement activities (e.g., advocacy groups)

Therapeutic areas Anti-Infectives, BioMedicines, Bone, Cardiovascular, Central Nervous System, Dermatology, Devices, Diabetes, Endocrinology, Eye Care, Gastroenterology, Internal Medicine, Immunology, Immuno-oncology, Medical Aesthetics, Metabolism, Oncology, Respiratory, Urology, and Virology